Andrew Wardlaw
- Longitudinal analysis of lung function decline with eosinophilic clustering in severe asthmaBy Chris Newby, Josh Agbetile, Beth Hargadon, Peter Bradding, Andrew Wardlaw, Ian Pavord, Ruth Green, Chris Brighling and Salman SiddiquiChris NewbyDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomJosh AgbetileDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomBeth HargadonDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomPeter BraddingDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomAndrew WardlawDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomIan PavordDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomRuth GreenDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomChris BrighlingDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United KingdomSalman SiddiquiDepartment of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United Kingdom
- Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAW039 in eosinophilic asthmaBy Sherif Gonem, Rachid Berair, Amisha Singapuri, Ruth Hartley, Marie Laurencin, Gerald Bacher, Chengxing Lu, Bjoern Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew Wardlaw, Salman Siddiqui, Richard Kay and Chris BrightlingSherif Gonem1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomRachid Berair1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomAmisha Singapuri1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomRuth Hartley1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomMarie Laurencin2Novartis, Novartis Pharmaceuticals AG, Basel, SwitzerlandGerald Bacher2Novartis, Novartis Pharmaceuticals AG, Basel, SwitzerlandChengxing Lu3Novartis, Novartis Pharamceuticals Corporation, East Hannover, NJ,Bjoern Holzhauer2Novartis, Novartis Pharmaceuticals AG, Basel, SwitzerlandMichelle Bourne1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomVijay Mistry1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomIan Pavord4Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomAdel Mansur5Severe and Brittle Asthma Unit, Birmingham Heartlands Hospital, Birmingham, United KingdomAndrew Wardlaw1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomSalman Siddiqui1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United KingdomRichard Kay2Novartis, Novartis Pharmaceuticals AG, Basel, SwitzerlandChris Brightling1Institute for Lung Health, NIHR Biomedical Research Unit, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, United Kingdom
- LATE-BREAKING ABSTRACT: Effect of QAW039, an oral prostaglandin D2 receptor (DP2/CRTh2) antagonist, upon bronchial epithelial integrity in treatment-resistant asthma in a randomized, placebo controlled studyBy Rachid Berair, Sherif Gonem, Amisha Singapuri, Ruth Hartley, Marie Laurencin, Gerald Bacher, Bjoern Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew Wardlaw, Salman Siddiqui, Richard Kay and Chris BrightlingRachid Berair1Institute for Lung Health, University of Leicester, Leicester, United KingdomSherif Gonem1Institute for Lung Health, University of Leicester, Leicester, United KingdomAmisha Singapuri1Institute for Lung Health, University of Leicester, Leicester, United KingdomRuth Hartley1Institute for Lung Health, University of Leicester, Leicester, United KingdomMarie Laurencin2Novartis Pharam AG, Novartis, Basel, SwitzerlandGerald Bacher3Novartis Pharma Corp, Novartis, East Hannover, NJ United StatesBjoern Holzhauer2Novartis Pharam AG, Novartis, Basel, SwitzerlandMichelle Bourne1Institute for Lung Health, University of Leicester, Leicester, United KingdomVijay Mistry1Institute for Lung Health, University of Leicester, Leicester, United KingdomIan Pavord4Respiratory Medicine, Oxford University, Oxford, United KingdomAdel Mansur5Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, United KingdomAndrew Wardlaw1Institute for Lung Health, University of Leicester, Leicester, United KingdomSalman Siddiqui1Institute for Lung Health, University of Leicester, Leicester, United KingdomRichard Kay2Novartis Pharam AG, Novartis, Basel, SwitzerlandChris Brightling1Institute for Lung Health, University of Leicester, Leicester, United Kingdom
- LATE-BREAKING ABSTRACT: IgE sensitisation to A. fumigatus is associated with fixed airflow obstruction independent of atopic statusBy Kerry Woolnough, Catherine Pashley and Andrew WardlawKerry Woolnough1Department of Infection Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, Leicester, United KingdomCatherine Pashley2Department of Infection Immunity and Inflammation, University of Leicester, Leicester, United KingdomAndrew Wardlaw1Department of Infection Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, Leicester, United Kingdom
- LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthmaBy Kerry Woolnough, Catherine Pashley and Andrew WardlawKerry Woolnough1Department of Infection Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, Leicester, United KingdomCatherine Pashley2Department of Infection Immunity and Inflammation, University of Leicester, Leicester, United KingdomAndrew Wardlaw1Department of Infection Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, Leicester, United Kingdom
- Infection associated phenotype of asthma: Results of a difficult asthma clinic service improvement projectBy Sushiladevi Natarajan, Robert Free, Andrew Wardlaw and Salman SiddiquiSushiladevi NatarajanRespiratory Biomedical Research Unit, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United KingdomRobert FreeRespiratory Biomedical Research Unit, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United KingdomAndrew WardlawRespiratory Biomedical Research Unit, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United KingdomSalman SiddiquiRespiratory Biomedical Research Unit, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.